Primer: Daihan Pharmaceutical (023910 KS) - Dec 2025
Dominant Niche Player with Strong Growth: Daihan Pharmaceutical is a leading manufacturer of intravenous (IV) solutions in South Korea, a...
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
No more insights